Cargando…
The clinical efficacy of type 2 monoclonal antibodies in eosinophil-associated chronic airway diseases: a meta-analysis
BACKGROUND: Anti-type 2 inflammation therapy has been proposed as a treatment strategy for eosinophil-associated chronic airway disorders that could reduce exacerbations and improve lung function. We performed a meta-analysis of randomized controlled trials to assess the effectiveness of type 2 mono...
Autores principales: | Wu, Yuan, Huang, Mengfen, Zhong, Jinyao, Lu, Yue, Gan, Kao, Yang, Rongyuan, Liu, Yuntao, Li, Jiqiang, Chen, Jiankun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126252/ https://www.ncbi.nlm.nih.gov/pubmed/37114057 http://dx.doi.org/10.3389/fimmu.2023.1089710 |
Ejemplares similares
-
Eosinophils in the Lung – Modulating Apoptosis and Efferocytosis in Airway Inflammation
por: Felton, Jennifer M., et al.
Publicado: (2014) -
Role of Matrix Metalloproteinase-2 in Eosinophil-Mediated Airway Remodeling
por: Kuwabara, Yu, et al.
Publicado: (2018) -
Clinical Characteristics and Outcomes of Hypertensive Patients Infected with COVID-19: A Retrospective Study
por: Chen, Liqin, et al.
Publicado: (2021) -
Production of monoclonal antibodies reactive with ovine eosinophils
por: Sansome, Georgina M, et al.
Publicado: (2007) -
Efficacy and safety of the innovative monoclonal antibodies in adults with generalized myasthenia gravis: a Bayesian network analysis
por: Chen, Huiru, et al.
Publicado: (2023)